Kura Oncology KURA Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's operating lease liabilities (total)?
- Kura Oncology (KURA) reported operating lease liabilities (total) of $14.52M in Q1 2026.
- How has Kura Oncology's operating lease liabilities (total) changed year-over-year?
- Kura Oncology's operating lease liabilities (total) increased by 48.5% year-over-year, from $9.78M to $14.52M.
- What is the long-term trend for Kura Oncology's operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Kura Oncology's operating lease liabilities (total) has grown at a 6.9% compound annual growth rate (CAGR), from $7.7M to $10.75M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.